Hims & Hers Health Reports Better-Than-Expected Q1 Results, Strong Guidance
Portfolio Pulse from Erica Kollmann
Hims & Hers Health Inc (NYSE:HIMS) reported Q1 earnings of 5 cents per share, surpassing the 2 cents estimate by 150%. Sales reached $278.171 million, beating estimates by 2.88% and marking a 45.81% year-over-year increase. Subscribers grew to 1.7 million, a 41% increase. The company projects Q2 revenue between $292 million and $297 million, and full-year revenue between $1.20 billion and $1.23 billion. HIMS shares rose 10.90% after-hours to $12.92.
May 06, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hims & Hers Health Inc reported strong Q1 results with earnings and sales surpassing estimates, significant subscriber growth, and provided optimistic revenue guidance for Q2 and the full year.
The positive earnings report and strong guidance indicate robust financial health and growth prospects for Hims & Hers Health, likely leading to increased investor confidence and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100